Quarterly report pursuant to Section 13 or 15(d)

Balance Sheet Details - Schedule of Accounts Payable and Accrued Liabilities (Details)

v3.20.4
Balance Sheet Details - Schedule of Accounts Payable and Accrued Liabilities (Details) - USD ($)
Jan. 31, 2021
Jul. 31, 2020
Balance Sheet Related Disclosures [Abstract]    
Research and development costs $ 6,152,870 $ 4,730,347
Professional services fees 2,362,178 3,097,881
Other 335,304 94,808
Total $ 8,850,352 $ 7,923,036